https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=23584116&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 235841162013070120211021
2168-34923442012Alcohol research : current reviewsAlcohol ResResilience to meet the challenge of addiction: psychobiology and clinical considerations.506515506-15Acute and chronic stress-related mechanisms play an important role in the development of addiction and its chronic, relapsing nature. Multisystem adaptations in brain, body, behavioral, and social function may contribute to a dysregulated physiological state that is maintained beyond the homeostatic range. In addition, chronic abuse of substances leads to an altered set point across multiple systems. Resilience can be defined as the absence of psychopathology despite exposure to high stress and reflects a person's ability to cope successfully in the face of adversity, demonstrating adaptive psychological and physiological stress responses. The study of resilience can be approached by examining interindividual stress responsibility at multiple phenotypic levels, ranging from psychological differences in the way people cope with stress to differences in neurochemical or neural circuitry function. The ultimate goal of such research is the development of strategies and interventions to enhance resilience and coping in the face of stress and prevent the onset of addiction problems or relapse.AlimTanja NTNDepartment of Psychiatry and Behavioral Sciences, Howard University, Washington, DC, USA.LawsonWilliam BWBFederAdrianaAIacovielloBrian MBMSaxenaShireenSBaileyChristopher RCRGreeneAllison MAMNeumeisterAlexanderAengR21 AA-018329AANIAAA NIH HHSUnited StatesRL1 AA-017540AANIAAA NIH HHSUnited StatesRL1 AA-017540-S1AANIAAA NIH HHSUnited StatesJournal ArticleResearch Support, N.I.H., Extramural
United StatesAlcohol Res1015944752168-34920Endocannabinoids0Neuropeptide Y333DO1RDJYSerotoninVTD58H1Z2XDopamineX4W3ENH1CVNorepinephrineIMAdaptation, PsychologicalphysiologyDopaminephysiologyEndocannabinoidsphysiologyHumansHypothalamo-Hypophyseal SystemphysiologyNeuropeptide YphysiologyNorepinephrinephysiologyPituitary-Adrenal SystemphysiologyResilience, PsychologicalSerotoninphysiologyStress, PsychologicalpsychologySubstance-Related Disorderspsychology
2013416602012110020137360201211ppublish23584116PMC3860393Ahmad S, Feder A, Lee EJ, et al. Earthquake impact in a remote South Asian population: Psychosocial factors and posttraumatic symptoms. Journal of Traumatic Stress. 2010;23(3):408–412.20564375Alim TN, Feder A, Graves RE, et al. Trauma, resilience, and recovery in a high-risk African-American population. American Journal of Psychiatry. 2008;165(12):1566–1575.19015233Astin JA. Stress reduction through mindfulness meditation: Effects on psychological symptomatology, sense of control, and spiritual experiences. Psychotherapy and Psychosomatics. 1997;66(2):97–106.9097338Bailey CR, Neumeister A. Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology. Neuroscience Letters. 2011;502(1):1–4.21787837Barr CS, Schwandt ML, Newman TK, Higley JD. The use of adolescent nonhuman primates to model human alcohol intake: Neurobiological, genetic, and psychological variables. Annals of the New York Academy of Sciences. 2004;1021:221–233.15251892Basavarajappa BS. The endocannabinoid signaling system: A potential target for next-generation therapeutics for alcoholism. Mini Reviews in Medicinal Chemistry. 2007;7(8):769–779.PMC197585817692039Basavarajappa BS, Yalamanchili R, Cravatt BF, et al. Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology. 2006;50(7):834–844.16448676Baumeister RF. Ego depletion and self-regulation failure: A resource model of self-control. Alcoholism: Clinical and Experimental Research. 2003;27(2):281–284.12605077Baumeister RF, Heatherton TF, Tice DM. Losing Control: How and Why People Fail at Self-Regulation. San Diego, CA: Academic Press; 1994.Beauregard M. Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Progress in Neurobiology. 2007;81(4):218–236.17349730Blednov YA, Cravatt BF, Boehm SL, 2nd, et al. Role of endocannabinoids in alcohol consumption and intoxication: Studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology. 2007;32(7):1570–1582.17164820Blomeyer D, Treutlein J, Esser G, et al. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biological Psychiatry. 2008;63(2):146–151.17597588Bonanno GA. Loss, trauma, and human resilience: Have we underestimated the human capacity to thrive after extremely aversive events? American Psychologist. 2004;59(1):20–28.14736317Brady KT, Sinha R. Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. American Journal of Psychiatry. 2005;162(8):1483–1493.16055769Brown SA, Vik PW, McQuaid JR, et al. Severity of psychosocial stress and outcome of alcoholism treatment. Journal of Abnormal Psychology. 1990;99(4):344–348.2266207Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review. 2006;26(1):17–31.16199119Campolongo P, Roozendaal B, Trezza V, et al. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(12):4888–4893.PMC266073219255436Carver CS. You want to measure coping but your protocol’s too long: Consider the brief COPE. International Journal of Behavioral Medicine. 1997;4(1):92–100.16250744Celerier A, Ognard R, Decorte L, Beracochea D. Deficits of spatial and non-spatial memory and of auditory fear conditioning following anterior thalamic lesions in mice: Comparison with chronic alcohol consumption. European Journal of Neuroscience. 2000;12:2575–2584.10947832Centers for Disease Control and Prevention, National Center for Health Statistics . Health, United States, 2003 with Chartbook on Trends in the Health of Americans. Washington, DC: Department of Health and Human Services; 2003. [ DHHS PHS No. 2003–1232].Charney DS. Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. American Journal of Psychiatry. 2004;161(2):195–216.14754765Charuvastra A, Cloitre M. Social bonds and post-traumatic stress disorder. Annual Review of Psychology. 2008;59:301–328.PMC272278217883334Cheer JF, Wassum KM, Sombers LA, et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. Journal of Neuroscience. 2007;27(4):791–795.PMC667292517251418Cicchetti D, Blender JA. A multiple-levels-of-analysis perspective on resilience: Implications for the developing brain, neural plasticity, and preventive interventions. Annals of the New York Academy of Sciences. 2006;1094:248–258.17347356Clark MS, Neumaier JF. The 5-HT1B receptor: Behavioral implications. Psychopharmacology Bulletin. 2001;35(4):170–185.12397864Colombo G, Serra S, Brunetti G, et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berlin) 2002;159(2):181–187.11862347Cooper ML, Russell M, Skinner JB, et al. Stress and alcohol use: Moderating effects of gender, coping, and alcohol expectancies. Journal of Abnormal Psychology. 1992;101(1):139–152.1537960Dai X, Thavundayil J, Santella S, Gianoulakis C. Response of the HPA-axis to alcohol and stress as a function of alcohol dependence and family history of alcoholism. Psychoneuroendocrinology. 2007;32(3):293–305.17349749Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: Self-medication and abdominal obesity. Brain, Behavior, and Immunity. 2005;19(4):275–280.15944067de Kloet ER, Derijk RH, Meijer OC. Therapy Insight: Is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nature Clinical Practice Endocrinology & Metabolism. 2007;3(2):168–179.17237843de Kloet ER, Joels M, Holsboer F. Stress and the brain: From adaptation to disease. Nature Reviews Neuroscience. 2005;6(6):463–475.15891777Delgado MR, Olsson A, Phelps EA. Extending animal models of fear conditioning to humans. Biological Psychology. 2006;73(1):39–48.16472906Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–1949.1470919Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994;372(6507):686–691.7990962Ding YS, Lin KS, Logan J, et al. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. Journal of Neurochemistry. 2005;94(2):337–351.15998285Dom G, De Wilde B, Hulstijn W, et al. Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. Alcoholism: Clinical and Experimental Research. 2006;30(10):1670–1677.17010134Drabant EM, Hariri AR, Meyer-Lindenberg A, et al. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry. 2006;63(12):1396–1406.17146014Drabant EM, McRae K, Manuck SB, et al. Individual differences in typical reappraisal use predict amygdala and prefrontal responses. Biological Psychiatry. 2009;65(5):367–373.PMC285568218930182Enoch MA. The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology. 2011;214(1):17–31.PMC300502220596857Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nature Reviews Neuroscience. 2009;10(6):446–457.PMC283310719455174Femenia T, Garcia-Gutierrez MS, Manzanares J. CB1 receptor blockade decreases ethanol intake and associated neurochemical changes in fawn-hooded rats. Alcoholism: Clinical and Experimental Research. 2010;34(1):131–141.19860799Folkman S, Moskowitz JT. Coping: Pitfalls and promise. Annual Review of Psychology. 2004;55:745–774.14744233Fredrickson BL. The role of positive emotions in positive psychology: The broaden-and-build theory of positive emotions. American Psychologist. 2001;56(3):218–226.PMC312227111315248Gallate JE, Saharov T, Mallet PE, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology. 1999;370(3):233–240.10334497Gianoulakis C, Dai X, Thavundayil J, Brown T. Levels and circadian rhythmicity of plasma ACTH, cortisol, and beta-endorphin as a function of family history of alcoholism. Psychopharmacology (Berlin) 2005;181(3):437–444.16133133Hakamata Y, Lissek S, Bar-Haim Y, et al. Attention bias modification treatment: A meta-analysis toward the establishment of novel treatment for anxiety. Biological Psychiatry. 2010;68(11):982–990.PMC329677820887977Hariri AR, Drabant EM, Munoz KE, et al. A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry. 2005;62(2):146–152.15699291Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biological Psychiatry. 2001;49(12):1023–1039.11430844Herkenham M, Groen BG, Lynn AB, et al. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Research. 1991;552(2):301–310.1913192Herkenham M, Lynn AB, Johnson MR, et al. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience. 1991;11(2):563–583.PMC65752151992016Hill MN, Hillard CJ, Bambico FR, et al. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences. 2009;30(9):484–493.19732971Hill MN, McEwen BS. Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(12):4579–4580.PMC266076119293387Hoebel BG, Avena NM, Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Current Opinion in Pharmacology. 2007;7(6):617–627.PMC272758918023617Hu J, Henry S, Gallezot JD, et al. Serotonin 1B receptor imaging in alcohol dependence. Biological Psychiatry. 2010;67(9):800–803.PMC311218120172504Hungund BL, Szakall I, Adam A, et al. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. Journal of Neurochemistry. 2003;84(4):698–704.12562514Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: The role of reward-related learning and memory. Annual Review of Neuroscience. 2006;29:565–598.16776597Johnstone T, van Reekum CM, Urry HL, et al. Failure to regulate: Counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. Journal of Neuroscience. 2007;27(33):8877–8884.PMC667216917699669Kalivas PW, Volkow ND. The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry. 2005;162(8):1403–1413.16055761Kirby LB, Zeeb FD, Winstanley CA. Contributions of serotonin in addiction vulnerability. Neuropharmacology. 2011;61(3):421–432.PMC311050321466815Kober H, Mende-Siedlecki P, Kross EF, et al. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(33):14811–14816.PMC293045620679212Koehnke MD, Schick S, Lutz U, et al. Severity of alcohol withdrawal symptoms and the T1128C polymorphism of the neuropeptide Y gene. Journal of Neural Transmission. 2002;109(11):1423–1429.12454738Koob GF. Alcoholism: Allostasis and beyond. Alcoholism: Clinical and Experimental Research. 2003;27(2):232–243.12605072Koob GF. Dynamics of neuronal circuits in addiction: Reward, antireward, and emotional memory. Pharmacopsychiatry. 2009;42(Suppl. 1):S32–S41.PMC273930519434554Koob GF, Ahmed SH, Boutrel B, et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews. 2004;27(8):739–749.15019424Koob GF, Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science. 1997;278(5335):52–58.9311926Koob GF, Le Moal M. Review: Neurobiological mechanisms for opponent motivational processes in addiction. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2008;363(1507):3113–3123.PMC260732618653439Krystal JH, Neumeister A. Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Research. 2009;1293:13–23.PMC276167719332037Lazarus RS, Fokman S. Stress, Appraisal, and Coping. New York: Springer; 1984.Le AD, Harding S, Juzytsch W, et al. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berlin) 2005;179(2):366–373.15551068Lee V, Cohen SR, Edgar L, et al. Clarifying “meaning” in the context of cancer research: A systematic literature review. Palliative & Supportive Care. 2004;2(3):291–303.16594414Lindell SG, Schwandt ML, Sun H, et al. Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Archives of General Psychiatry. 2010;67(4):423–431.PMC296362420368518Maccioni P, Pes D, Carai MA, et al. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behavioural Pharmacology. 2008;19(3):197–209.18469537Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook of Experimental Pharmacology. 2005;168:299–325.16596779MacQueen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(3):1387–1392.PMC29878212552118Malinen H, Hyytia P. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcoholism: Clinical and Experimental Research. 2008;32(11):1976–1983.18782338Mangieri RA, Hong KI, Piomelli D, Sinha R. An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics. Psychopharmacology (Berlin) 2009;205(1):63–72.PMC271516419343330Marinelli PW, Bai L, Quirion R, Gianoulakis C. A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcoholism: Clinical and Experimental Research. 2005;29(10):1821–1828.16269911Marinelli PW, Funk D, Juzytsch W, et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berlin) 2007;195(3):345–355.17705061Marlatt GA. Should abstinence be the goal for alcohol treatment? Negative viewpoint. American Journal on Addictions. 2001;10(4):291–293.11783743Masten AS. Ordinary magic: Resilience processes in development. American Psychologist. 2001;56(3):227–238.11315249Masten AS, Coatsworth JD. The development of competence in favorable and unfavorable environments: Lessons from research on successful children. American Psychologist. 1998;53(2):205–220.9491748Matsuda LA, Bonner TI, Lolait SJ. Localization of cannabinoid receptor mRNA in rat brain. Journal of Comparative Neurology. 1993;327(4):535–550.8440779McCool BA, Christian DT, Diaz MR, Lack AK. Glutamate plasticity in the drunken amygdala: The making of an anxious synapse. International Review of Neurobiology. 2010;91:205–233.PMC303260420813244McEwen BS. Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology. 2000;22(2):108–124.10649824McEwen BS. Mood disorders and allostatic load. Biological Psychiatry. 2003;54(3):200–207.12893096Mechoulam R, Ben-Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology. 1995;50(1):83–90.7605349Milad MR, Quinn BT, Pitman RK, et al. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(30):10706–10711.PMC118077316024728Miller WR, Westerberg VS, Harris RJ, Tonigan JS. What predicts relapse? Prospective testing of antecedent models. Addiction. 1996;91(Suppl):S155–S172.8997790Miner LH, Jedema HP, Moore FW, et al. Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. Journal of Neuroscience. 2006;26(5):1571–1578.PMC667548816452680Morgan CA, 3rd, Wang S, Southwick SM, et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry. 2000;47(10):902–909.10807963Mottagui-Tabar S, Prince JA, Wahlestedt C, et al. A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcoholism: Clinical and Experimental Research. 2005;29(5):702–707.15897713Naassila M, Pierrefiche O, Ledent C, Daoust M. Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology. 2004;46(2):243–253.14680762Neumeister A, Charney DS, Belfer I, et al. Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenetics and Genomics. 2005;15(3):143–149.15861038O’Brien CP, Childress AR, Ehrman R, Robbins SJ. Conditioning factors in drug abuse: Can they explain compulsion? Journal of Psychopharmacology. 1998;12(1):15–22.9584964O’Donnell T, Hegadoren KM, Coupland NC. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology. 2004;50(4):273–283.15539856Ong AD, Bergeman CS, Bisconti TL, Wallace KA. Psychological resilience, positive emotions, and successful adaptation to stress in later life. Journal of Personality and Social Psychology. 2006;91(4):730–749.17014296Pargament KI, Smith BW, Koenig HG, Perez L. Patterns of positive and negative religious coping with major life stressors. Journal for the Scientific Study of Religion. 37:710–724.Pezawas L, Meyer-Lindenberg A, Drabant EM, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nature Neuroscience. 2005;8(6):828–834.15880108Poncelet M, Maruani J, Calassi R, Soubrie P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neuroscience Letters. 2003;343(3):216–218.12770700Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research—past, present, and future. Biological Psychiatry. 2006;60(4):376–382.16919525Richardson K, Baillie A, Reid S, et al. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction. 2008;103(6):953–959.18482418Robles TF, Kiecolt-Glaser JK. The physiology of marriage: Pathways to health. Physiology & Behavior. 2003;79(3):409–416.12954435Roffman JL, Marci CD, Glick DM, et al. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychological Medicine. 35(10):1385–1398.16164763Ross S, Peselow E. The neurobiology of addictive disorders. Clinical Neuropharmacology. 2009;32(5):269–276.19834992Rutter M. Resilience in the face of adversity: Protective factors and resistance to psychiatric disorder. British Journal of Psychiatry. 1985;147:598–611.3830321Sallinen J, Haapalinna A, MacDonald E, et al. Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Molecular Psychiatry. 1999;4(5):443–452.10523817Sari Y. Serotonin1B receptors: From protein to physiological function and behavior. Neuroscience and Biobehavioral Reviews. 2004;28(6):565–582.15527863Schmid B, Blomeyer D, Treutlein J, et al. Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. International Journal of Neuropsychopharmacology. 2010;13(6):703–714.19607758Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Archives of General Psychiatry. 1996;53(3):202–210.8611056Seligman ME, Csikszentmihalyi M. Positive psychology: An introduction. American Psychologist. 2000;55(1):5–14.11392865Selye H. The Stress of Life. New York: McGraw-Hill; 1976.Shapiro SL, Schwartz GE, Bonner G. Effects of mindfulness-based stress reduction on medical and pre-medical students. Journal of Behavioral Medicine. 1998;21(6):581–599.9891256Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berlin) 2001;158(4):343–359.11797055Sinha R, Fox HC, Hong KI, et al. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Archives of General Psychiatry. 2011;68(9):942–952.PMC366898121536969Small KM, Forbes SL, Rahman FF, et al. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. Journal of Biological Chemistry. 2000;275(30):23059–23064.10801795Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annual Review of Clinical Psychology. 2005;1:255–291.17716089Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 1997;388(6644):773–778.9285589Stephens DN, Ripley TL, Borlikova G, et al. Repeated ethanol exposure and withdrawal impairs human fear conditioning and depresses long-term potentiation in rat amygdala and hippocampus. Biological Psychiatry. 2005;58(5):392–400.16018978Sterling P, Eyer J. Allostasis: A New Paradigm to Explain Arousal Pathology. New York: John Wiley & Sons; 1988.Sugiura T, Kondo S, Sukagawa A, et al. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications. 1995;215(1):89–97.7575630Sullivan EV, Pfefferbaum A. Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology (Berlin) 2005;180(4):583–594.15834536Teasdale JD, Segal ZV, Williams JM, et al. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology. 2000;68(4):615–623.10965637Thanos PK, Michaelides M, Umegaki H, Volkow ND. D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse. 2008;62(7):481–486.PMC265901618418874Thiele TE, Marsh DJ, Ste Marie L, et al. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 1998;396(6709):366–369.9845072Thorsell A. Neuropeptide Y (NPY) in alcohol intake and dependence. Peptides. 2007;28(2):480–483.17239487Tugade MM, Fredrickson BL. Resilient individuals use positive emotions to bounce back from negative emotional experiences. Journal of Personality and Social Psychology. 2004;86(2):320–333.PMC313255614769087Van Sickle MD, Duncan M, Kingsley PJ, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310(5746):329–332.16224028Veenstra MY, Lemmens PH, Friesema IH, et al. Coping style mediates impact of stress on alcohol use: A prospective population-based study. Addiction. 2007;102(12):1890–1898.18031425Vinod KY, Hungund BL. Cannabinoid-1 receptor: A novel target for the treatment of neuropsychiatric disorders. Expert Opinion on Therapeutic Targets. 2006;10(2):203–210.16548770Vinod KY, Sanguino E, Yalamanchili R, et al. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol. Journal of Neurochemistry. 2008b;104(1):233–243.17944864Vinod KY, Yalamanchili R, Thanos PK, et al. Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse. 2008a;62(8):574–581.PMC266710418509854Vinod KY, Yalamanchili R, Xie S, et al. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochemistry International. 2006;49(6):619–625.16822589Vinod KY, Kassir SA, Hungund BL, et al. Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. Journal of Psychiatric Research. 2010;44(9):591–597.PMC287884720015515Volkow ND, Fowler JS, Wang GJ. Role of dopamine in drug reinforcement and addiction in humans: Results from imaging studies. Behavioural Pharmacology. 2002;13(5–6):355–366.12394411Volkow ND, Wang GJ, Begleiter H, et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: Possible protective factors. Archives of General Psychiatry. 2006;63(9):999–1008.16953002Volkow ND, Wang GJ, Fowler JS, et al. Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain’s control circuit. BioEssays. 2010;32(9):748–755.PMC294824520730946Volkow P, Tellez O, Allende S, Vazquez C. Drug abuse through a long-indwelling catheter cared for by an intravenous team. American Journal of Infection Control. 1999;27(5):459.10511497Vythilingam M, Nelson EE, Scaramozza M, et al. Reward circuitry in resilience to severe trauma: An fMRI investigation of resilient special forces soldiers. Psychiatry Research. 2009;172(1):75–77.PMC276085219243926Wager TD, Davidson ML, Hughes BL, et al. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron. 2008;59(6):1037–1050.PMC274232018817740Wetherill L, Schuckit MA, Hesselbrock V, et al. Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcoholism: Clinical and Experimental Research. 2008;32(12):2031–2040.PMC265044118828811Wills TA, Sandy JM, Yaeger AM, et al. Coping dimensions, life stress, and adolescent substance use: A latent growth analysis. Journal of Abnormal Psychology. 110(2):309–323.11358025Yacubian J, Sommer T, Schroeder K, et al. Gene–gene interaction associated with neural reward sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(19):8125–8130.PMC186491017483451Yehuda R, LeDoux J. Response variation following trauma: A translational neuroscience approach to understanding PTSD. Neuron. 2007;56(1):19–32.17920012Zhang H, Sakharkar AJ, Shi G, et al. Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats. Alcoholism: Clinical and Experimental Research. 2010;34(3):451–461.PMC285825720028368